United States · FDA National Drug Code directory
lansoprazole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45802-878_5032a392-a20a-4246-b2cb-54d7e3a441f8
- Product NDC
- 45802-878
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- Lansoprazole
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210729
- Source listing expiry
- 20261231
Source-listed ingredients
- LANSOPRAZOLE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (45802-878-01) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE · 45802-878-01
- 2 BOTTLE in 1 CARTON (45802-878-02) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE · 45802-878-02
- 3 BOTTLE in 1 CARTON (45802-878-03) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE · 45802-878-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →